%0 Journal Article
%T Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial¡ªClinical outcomes and molecular determinants of response
%A Andrea Muscat
%A Caitlin Murphy
%A David Ashley
%A David Chisanga
%A Geoffrey Lindeman
%A Ian Collins
%A Linda West
%A Mustafa Khasraw
%A Sally Baron-Hay
%A Sujata Patil
%A Violet Mukaro
%A Wei Shi
%A Yang Liao
%J Archive of "PLoS ONE".
%D 2019
%R 10.1371/journal.pone.0210891
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375556/